In a clinical study, following Infliximab infusion, the percentage of cases with transient improvement of endothelial function (endothelial-dependent vasodilation) increased, suggesting that long-term TNF blockade reduces the high incidence of CVD complication in RA [44]. This evidence concerns the gene TNF and rheumatoid arthritis.